Gregory Sahlem (@gregorysahlem) 's Twitter Profile
Gregory Sahlem

@gregorysahlem

ID: 1205807615860772865

calendar_today14-12-2019 11:12:21

26 Tweet

65 Followers

318 Following

Magnus Medical (@magnusmed) 's Twitter Profile Photo

The FDA has granted Breakthrough Device Designation for our individualized, #non-invasive, investigational #neuromodulation technology for people with major #depression. More here: ow.ly/Utws50GB4mL #fMRI #targeted #brainhealth #mentalhealth #targeted

The FDA has granted Breakthrough Device Designation for our individualized, #non-invasive, investigational #neuromodulation technology for people with major #depression. More here: ow.ly/Utws50GB4mL
#fMRI #targeted #brainhealth #mentalhealth #targeted
Nolan Williams (@nolanrywilliams) 's Twitter Profile Photo

Encouraging data in Journals of The American Psychiatric Association from our double-blinded RCT evaluating Stanford Neuromodulation Therapy (SNT) for treatment-resistant #depression. After 5 days, 79% in the active group experienced remission from depression compared to 13% in sham. ajp.psychiatryonline.org/doi/10.1176/ap…

Encouraging data in <a href="/APAPubJournals/">Journals of The American Psychiatric Association</a> from our double-blinded RCT evaluating Stanford Neuromodulation Therapy (SNT) for treatment-resistant #depression. After 5 days, 79% in the active group experienced remission from depression compared to 13% in sham. ajp.psychiatryonline.org/doi/10.1176/ap…
Corey Keller (@drcoreykeller) 's Twitter Profile Photo

Effects of transcranial magnetic stimulation on the human brain recorded with intracranial electrocorticography: First-in-human study biorxiv.org/content/10.110… (thread coming soon)

Colleen Hanlon (@brainstimgrl) 's Twitter Profile Photo

Yay! Despite my initial skepticism, it turns out that 600 Pulses of iTBS does in fact cause reliable cortical facilitation in a stable Brain state. *** Breaking news: we have already replicated this experiment with similar results!!! *** Czoty_lab@Wake @LindseyGalboMS Paul Czoty

Kevin Caulfield (@kevinacaulfield) 's Twitter Profile Photo

Excited to share our new #openaccess paper comparing Rogue Research neuronavigated vs. cap-based #TMS targeting in 11,230 measurements across 42 participants, out now in Brain Stimulation. 4 take-home points 🧵 1/5 brainstimjrnl.com/article/S1935-…

Flint M. Espil, Ph.D. (@espilphd) 's Twitter Profile Photo

sciencedirect.com/science/articl… Another paper to come out of our work on long-term effects of behavior therapy for youth with tics/Tourette. We examined the question we so often receive from parents, "What happens to tics as we get older?" TouretteAssn tourette awareness

Magnus Medical (@magnusmed) 's Twitter Profile Photo

We expect commercial launch of #SAINT to begin later in '23 on a limited basis. We're building a significant waitlist and engaging with multiple teaching institutions, hospitals, clinics, clinicians, and medical professionals. Join our waitlist here: ow.ly/rwfr50KEZNT

We expect commercial launch of #SAINT to begin later in '23 on a limited basis. We're building a significant waitlist and engaging with multiple teaching institutions, hospitals, clinics, clinicians, and medical professionals. Join our waitlist here:
ow.ly/rwfr50KEZNT
Brain Stimulation (@brainstimj) 's Twitter Profile Photo

We are pleased to announce, Colleen Hanlon, PhD, is the recipient of the 2023 International Brain Stimulation Early Career Award, which will be presented at the #BrainStimConf, 18-22 Feb, 2023, in Portugal. Learn more about Colleen Hanlon here. elsevier.com/events/confere…

Dr. Azeezat Azeez (@dr_azeezatazeez) 's Twitter Profile Photo

New publication! We explore resting-state changes associated with the clinical improvements induced by the Stanford Neuromodulation Therapy (SNT) TMS. Special thanks to Brain Stimulation Lab #tms #neuroimaging #psychiatry #depression #neurostimulation #restingstate #stanfordmedicine

Wellcome Leap (@wellcomeleap) 's Twitter Profile Photo

Worldwide, someone dies from drug or alcohol addiction every 4 minutes. Wellcome Leap's $50M Untangling Addiction program seeks breakthroughs that will quantify addiction susceptibility and reduce the risk of relapse. Learn more: bit.ly/47dn2tO

Worldwide, someone dies from drug or alcohol addiction every 4 minutes. 

Wellcome Leap's $50M Untangling Addiction program seeks breakthroughs that will quantify addiction susceptibility and reduce the risk of relapse.

Learn more: bit.ly/47dn2tO